411 followers
RT @FrontPharmacol: New Research: Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmac…
RT @FrontPharmacol: New Research: Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmac…
New Research: Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmacokinetic/pharmacodynamic analysis https://t.co/wlVKfepuR4 #pharmacology